Ericksen Scott D sold $58K of ILMN
Ericksen Scott D (VP, Chief Accounting Officer) sold 267 shares of ILLUMINA, INC. (ILMN) at $217.76 on 2026-11-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and unlikely to move the stock materially, but it adds to the flow of insider activity data that traders monitor.
Market read
A small insider sell; minimal immediate impact but useful for monitoring insider sentiment.
What to watch
The insider retains a large stake (14,029 shares) and the sale was pre‑arranged under a 10b5‑1 plan.
Background
Illumina is a leading provider of sequencing and genomic analysis tools. Insider transactions are regularly disclosed via Form 4.
Ticker impact
SEC Form 4 shows VP and CFO Ericksen Scott D sold 267 shares of Illumina at $217.76, a $58K transaction.
likely modest pressure as the market prices in the insider sale
The sale is small relative to total holdings and recent price, but insider sales can prompt short‑term downside bias.
Market effects
None significant for the genomics sector.
No regional effect.
Limited to Illumina investors.
Counterpoint
The sale could be routine portfolio rebalancing, not a bearish signal.
Key entities
- companyIllumina, Inc.
US‑listed genomics company (ticker ILMN).
- personEricksen Scott D
Vice President, Chief Accounting Officer at Illumina.


